ユーザーIDをお忘れですか? or パスワードをお忘れですか?

東京ビッグサイト | 有明

2018年11月11日 (日) 午前 9:30 - 2018年11月13日 (火) 午後 5:40

〒135-0063, 東京都江東区有明3-11-1



[V1-S5] What Information and Communication Do Patients Want in Clinical Trials? How We Can Provide Them? (Part 1)

Session Chair(s)

Yasuhiro  Fujiwara, MD, PhD

Yasuhiro Fujiwara, MD, PhD

Chief Executive

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Yoshikata  Furuya, MSc

Yoshikata Furuya, MSc

Manager, General Affairs Division

Sankeien Hoshoukai Foundation, Japan

In order to engage patients as a partner in drug development and promote their involvement, it is important to understand patients’ needs in information and communication in clinical trials then provide them to patients. Disclosure of clinical trial information and provision of lay summaries of clinical trial results are beginning to be carried out in Japan. This session aims to understand what information and communication patients are seeking before, during and after clinical trials, and discuss how we should provide them to patients based on the regulations and case studies in Japan and global. In part 1 session, industry’s efforts, opinions from clinical trial sites and patients in Japan will be shared. In part 2 session, global status on patient communication will be stared and all speakers of part 1 and 2 sessions will have a panel discussion.


Atsushi  Kitamura, MS

Clinical Trial Information for Patients - Current Status and Obstacles in Pharma Company -

Atsushi Kitamura, MS

Pfizer R&D Japan G.K., Japan

Director, Clinical Development Quality

Nobuko  Ushirozawa, RN

Providing Information to Patients Who Participate in Clinical Trials: Efforts by Trial Sites

Nobuko Ushirozawa, RN

National Cancer Center, Japan

Chief, Research Admin. Div. Center for Research Admin and Support

Naomi  Sakurai

Patients’ Needs in Communication and Information Sharing in Clinical Trials -1 - A cancer patient’s perspective-

Naomi Sakurai

CSR-Project, NPO, Japan


Hiroki  Takeda

Patients’ Needs in Patient Communication and Information Sharing in Clinical Trials

Hiroki Takeda

Japan Chronic Diseases Self-Management Association, Japan

Executive Director